DCF — MEADVILLE MEDICAL CENTER
Enterprise Value: $-151.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-151.1M
Enterprise Value
$-52.8M
PV of Cash Flows
$-98.3M
PV of Terminal Value
$-158.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $244.2M | $-6.7M | -3.0% | $-17.0M | $-15.5M |
| Year 2 | $251.5M | $-4.4M | -2.0% | $-15.0M | $-12.4M |
| Year 3 | $259.1M | $-1.9M | -1.0% | $-12.9M | $-9.7M |
| Year 4 | $266.9M | $-0.6M | -0.0% | $-11.9M | $-8.1M |
| Year 5 | $274.9M | $0.1M | 0.0% | $-11.6M | $-7.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-151.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$237.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03229461217525079
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5